Apolipoprotein CIII Reduction Via Colchicine

Summary

The aim of this trial will be to determine an effect-size for the administration of chronic low-dose colchicine in the reduction of serum levels of triglycerides (TG), very-low density lipoproteins (VLDL), and apolipoprotein CIII (apoCIII) in human subjects over a period of 4-6 weeks.

Timeline

Start

2014-02

Primary completion

2014-05

Completion

2014-05

Drugs

Indications